USPTO serial 79279254
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $975
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ryan M. Kaiser
Ryan M. Kaiser Amin Talati Wasserman LLP549 W. Randolph St., Suite 400Chicago, IL 60661United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for research purposes for pharmaceuticals, regenerative medicine, and implantable medical apparatus and instruments, other than for medical or veterinary purposes; biological cell culture mediums for scientific and research purposes for pharmaceuticals, regenerative medicine, and implantable medical apparatus and instruments; biological cell culture mediums used for regenerative medicine or for use in the manufacture of pharmaceuticals; industrial chemicals for research purposes for pharmaceuticals, regenerative medicine, and implantable medical apparatus and instruments; chemicals for use in the manufacture of biological cell culture media for pharmaceuticals and regenerative medicine; chemicals for use in the manufacture of pharmaceuticals and implantable medical apparatus and instruments; plant growth regulating preparations; higher fatty acids for industrial use; artificial sweeteners; gelatine for use in the manufacture of cosmetics; collagen peptides for use in the manufacture of cosmetics; chemical compositions for developing photographs | ACTIVE | — |
| 005 | Gelatine for medical purposes, namely, gelatine for use as a hemostatic, gelatine for use as an adhesive for binding wounds, gelatine for use as anti-adhesion gels for wound drainage devices, gelatine for use as a lubricant for artificial blood vessels and catheters, and gelatine for use as an adhesive to biotissue for artificial blood vessels and catheters; collagen for medical purposes; collagen peptides for medical purposes; in vitro diagnostic reagents for medical and veterinary use; microorganism culture mediums for regenerative medicine purposes; pharmaceutical preparations, namely, hemostatics, medical adhesives for binding wounds, and anti-adhesion gels for use with wound drainage devices for surgical treatment; pharmaceutical preparations, namely, biological cell culture mediums for regenerative medicine purposes and biological preparations for use as a hemostatic, for use as an adhesive for binding wounds, for use as anti-adhesion gels for wound drainage devices, for use as a medical lubricant for artificial blood vessels and catheters, and for use as a medical adhesive to biotissue for artificial blood vessels and catheters; dental materials, namely, dental ceramics, dental cement; lactose for pharmaceutical purposes; lacteal flour for babies; cotton swabs for medical use | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, medical endoscopes, catheters, medical ultrasound apparatus, medical devices for nonsurgical cosmetic treatments, medical devices for closing wounds, hemostatic suture instruments, medical and surgical instruments and apparatus for preventing the formation of adhesions after surgical procedures, artificial blood vessels, artificial joints; pacifiers for babies; ice bag pillows for medical purposes; triangular bandages for anatomical joints; supportive bandages; surgical catguts; feeding cups for medical purposes; dropping pipettes for medical purposes; feeding bottle teats; medical ice bags; medical ice bag holders, namely, medical apparatus in the nature of dispensers for plastic ice bags; baby bottles; nursing bottles; finger guards for medical purposes; non-chemical contraceptives, namely, contraceptive apparatus; artificial tympanic membranes; prosthetics or fillings materials, namely, artificial materials for use in the replacement of bones and cartilage; bracelets for medical purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 29, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jul 12, 2024 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jul 8, 2024 | A7OK | AMENDMENT UNDER SECTION 7 - PROCESSED | — |
| Jul 3, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 28, 2023 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| May 20, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 12, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 16, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 16, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 4, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 17, 2022 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 9, 2022 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Feb 2, 2022 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jan 21, 2022 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 21, 2022 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 28, 2021 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Nov 21, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Aug 18, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Aug 7, 2021 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 21, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 21, 2021 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 18, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 30, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 30, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 30, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 17, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 17, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 17, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 17, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 17, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 22, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 22, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 22, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 1, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 1, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 1, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2020 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2020 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| May 8, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 10, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 24, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 24, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 4, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 3, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 29, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 25, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 25, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 20, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |